| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |